Skip to content

Neveen A Kohaf

Department of Clinical Pharmacy, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.

2 papers in the library · 8 citations · publishing 2025

Papers

Safety considerations and risk mitigation strategies for ketamine use: a comprehensive review.

Annals of medicine and surgery (2012) May 1, 2025 Reem Sayad, Ahmed Saad Elsaeidy, Amna M Anis et al. 7 citations

Ketamine, a dissociative anesthetic, is used for anesthesia, pain management, and treatment-resistant depression, but safety concerns persist. This review summarizes adverse effects, particularly cardiovascular, neuropsychiatric, and dependency risks. Evidence-based guidelines for administration, dosing, and monitoring are discussed, emphasizing risk-benefit assessments. Future directions include enhanced safety protocols, long-term outcomes, and individualized dosing.

A Promising Route for Established Indications: A Systematic Review of Nebulized Ketamine in Pain.

Current pain and headache reports April 30, 2025 Neveen A Kohaf, Tabia Imtiyaz Khan, Hamada Hamdy Elbana et al. 1 citation

Nebulized ketamine offers a promising alternative for pain management, providing rapid absorption and effective delivery with potentially fewer side effects and better patient compliance due to the smaller volume required for nebulization. A systematic review of nine primary studies indicates that nebulized ketamine is a safe and efficacious treatment for acute pain. However, the evidence is still emerging, and further research is needed to understand its pharmacokinetics, optimal dosing, and efficacy across different populations.